• Investing
  • Stock
  • Editor’s Pick
  • Economy
The Significant Deals
Stock

Meta releases AI model to enhance Metaverse experience

by December 13, 2024
written by December 13, 2024

(Reuters) – Meta (NASDAQ:META) said on Thursday it was releasing an artificial intelligence model called Meta Motivo, which could control the movements of a human-like digital agent, with the potential to enhance Metaverse experience.

The company has been plowing tens of billions of dollars into its investments in AI, augmented reality and other Metaverse technologies, driving up its capital expense forecast for 2024 to a record high of between $37 billion and $40 billion.

Meta has also been releasing many of its AI models for free use by developers, believing that an open approach could benefit its business by fostering the creation of better tools for its services.

“We believe this research could pave the way for fully embodied agents in the Metaverse, leading to more lifelike NPCs, democratization of character animation, and new types of immersive experiences,” the company said in a statement.

Meta Motivo addresses body control problems commonly seen in digital avatars, enabling them to perform movements in a more realistic, human-like manner, the company said.

Meta said it was also introducing a different training model for language modeling called the Large Concept Model (LCM), which aims to “decouple reasoning from language representation”.

“The LCM is a significant departure from a typical LLM. Rather than predicting the next token, the LCM is trained to predict the next concept or high-level idea, represented by a full sentence in a multimodal and multilingual embedding space,” the company said.

Other AI tools released by Meta include the Video Seal, which embeds a hidden watermark into videos, making it invisible to the naked eye but traceable.

This post appeared first on investing.com
0 comment
0
FacebookTwitterPinterestEmail

previous post
Global EV sales hit third consecutive record high
next post
Private Medicare plans must cover Biogen’s ALS drug, US agency says

You may also like

BASF results down on impairments, restructuring

January 27, 2025

Nasdaq futures tumble as China’s AI push rattles...

January 27, 2025

European chipmakers slump as traders gauge DeepSeek AI...

January 27, 2025

China Vanke’s CEO, chairman resign amid growing liquidity...

January 27, 2025

Fuji Media, rocked by sexual misconduct allegations, says...

January 27, 2025

Italy’s MPS shares fall ahead of Mediobanca board...

January 27, 2025

British Land stock drops following stake sale

January 27, 2025

UMG shares rally after new multi-year pact with...

January 27, 2025

BASF shares indicated 3% lower as impairments drag...

January 27, 2025

Ryanair cuts 2026 traffic forecast amid ongoing Boeing...

January 27, 2025
Fill Out & Get More Relevant News








    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Recent Posts

    • Procter & Gamble to cut 7,000 jobs as part of broader restructuring

      June 6, 2025
    • Shein and Temu see U.S. demand plunge as loophole for cheap goods closes

      June 6, 2025
    • Shein and Temu see U.S. demand plunge as loophole for cheap goods closes

      June 5, 2025
    • This California startup is cleaning water and removing CO₂ from the atmosphere — all at a reduced cost

      June 5, 2025

    Categories

    • Economy (245)
    • Editor's Pick (3,646)
    • Investing (504)
    • Stock (6,426)

    Latest News

    • Procter & Gamble to cut 7,000 jobs as part of broader restructuring
    • Shein and Temu see U.S. demand plunge as loophole for cheap goods closes

    Popular News

    • GM lays off 1,000 employees amid reorganization and cost-cutting
    • Microsoft launches two data center infrastructure chips to speed AI applications

    About The Significant deals

    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 thesignificantdeals.com | All Rights Reserved

    The Significant Deals
    • Investing
    • Stock
    • Editor’s Pick
    • Economy